XML 20 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Shareholders' Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Jan. 01, 2022   22,683    
Beginning balance at Jan. 01, 2022 $ (424,953) $ 227 $ 3,971 $ (429,151)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 2,074     2,074
Exercise of common stock options (in shares)   21    
Exercise of common stock options 531   531  
Stock-based compensation (in shares)   341    
Stock-based compensation 4,133 $ 3 4,130  
Repurchases of common stock (in shares)   (813)    
Repurchases of common stock (50,998) $ (8) (8,632) (42,358)
Ending balance (in shares) at Apr. 02, 2022   22,232    
Ending balance at Apr. 02, 2022 (469,213) $ 222 0 (469,435)
Beginning balance (in shares) at Jan. 01, 2022   22,683    
Beginning balance at Jan. 01, 2022 (424,953) $ 227 3,971 (429,151)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 42,040      
Ending balance (in shares) at Oct. 01, 2022   22,001    
Ending balance at Oct. 01, 2022 (437,471) $ 220 458 (438,149)
Beginning balance (in shares) at Apr. 02, 2022   22,232    
Beginning balance at Apr. 02, 2022 (469,213) $ 222 0 (469,435)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 34,933     34,933
Exercise of common stock options (in shares)   2    
Exercise of common stock options 54   54  
Stock-based compensation (in shares)   26    
Stock-based compensation 3,910 $ 1 3,909  
Repurchases of common stock (in shares)   (296)    
Repurchases of common stock (12,646) $ (3) (3,963) (8,680)
Ending balance (in shares) at Jul. 02, 2022   21,964    
Ending balance at Jul. 02, 2022 (442,962) $ 220 0 (443,182)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 5,033     5,033
Exercise of common stock options (in shares)   19    
Exercise of common stock options 413   413  
Stock-based compensation (in shares)   30    
Stock-based compensation 542   542  
Repurchases of common stock (in shares)   (12)    
Repurchases of common stock (497)   (497)  
Ending balance (in shares) at Oct. 01, 2022   22,001    
Ending balance at Oct. 01, 2022 $ (437,471) $ 220 458 (438,149)
Beginning balance (in shares) at Dec. 31, 2022 22,014 22,014    
Beginning balance at Dec. 31, 2022 $ (438,177) $ 220 5,182 (443,579)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 11,465     11,465
Exercise of common stock options (in shares)   17    
Exercise of common stock options 389   389  
Stock-based compensation (in shares)   271    
Stock-based compensation 4,639 $ 3 4,636  
Repurchases of common stock (in shares)   (118)    
Repurchases of common stock (3,363) $ (1) (3,362)  
Ending balance (in shares) at Apr. 01, 2023   22,184    
Ending balance at Apr. 01, 2023 $ (425,047) $ 222 6,845 (432,114)
Beginning balance (in shares) at Dec. 31, 2022 22,014 22,014    
Beginning balance at Dec. 31, 2022 $ (438,177) $ 220 5,182 (443,579)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) $ 9,901      
Ending balance (in shares) at Sep. 30, 2023 22,228 22,228    
Ending balance at Sep. 30, 2023 $ (420,687) $ 222 12,769 (433,678)
Beginning balance (in shares) at Apr. 01, 2023   22,184    
Beginning balance at Apr. 01, 2023 (425,047) $ 222 6,845 (432,114)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 754     754
Exercise of common stock options (in shares)   3    
Exercise of common stock options 39   39  
Stock-based compensation (in shares)   33    
Stock-based compensation 5,251   5,251  
Repurchases of common stock (in shares)   (6)    
Repurchases of common stock (138)   (138)  
Ending balance (in shares) at Jul. 01, 2023   22,214    
Ending balance at Jul. 01, 2023 (419,141) $ 222 11,997 (431,360)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (2,318)     (2,318)
Exercise of common stock options (in shares)   0    
Exercise of common stock options 0   0  
Stock-based compensation (in shares)   22    
Stock-based compensation 982   982  
Repurchases of common stock (in shares)   (8)    
Repurchases of common stock $ (210)   (210)  
Ending balance (in shares) at Sep. 30, 2023 22,228 22,228    
Ending balance at Sep. 30, 2023 $ (420,687) $ 222 $ 12,769 $ (433,678)